1. Home
  2. BRTX

BRTX

BioRestorative Therapies Inc. (NV)

Logo BioRestorative Therapies Inc. (NV)

Health Care

Managed Health Care

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Founded: 1997 Country:
United States
United States
Employees: N/A City: MELVILLE
Market Cap: 8.7M IPO Year: N/A
Target Price: $15.00 AVG Volume (30 days): 656.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.42 EPS Growth: N/A
52 Week Low/High: $1.20 - $7.13 Next Earning Date: 05-10-2024
Revenue: $145,800 Revenue Growth: 21.70%
Revenue Growth (this year): -58.02% Revenue Growth (next year): N/A

Share on Social Networks: